Legal Opinion
Akerman v. GlaxoSmithKline, LCC
District Court, D. Massachusetts
Decided August 4, 2017No. MDL No. 1:15-md-2657-FDS; Case No. 1:16-cv-12471-FDS, Case No. 1:15-cv-13749-FDS, Case No. 1:16-cv-10665-FDS, Case No. 1:16-cv-12213-FDS, Case No. 1:16-cv-10199-FDS, Case No. 1:16-cv-11748-FDSPublishedCited by 1 opinion
1Opinion of the Court
*64MEMORANDUM AND ORDER ON DEFENDANT’S CONSOLIDATED MOTION TO DISMISS FOR FAILURE TO PLEAD USE OF ITS PRODUCT; DEFENDANT’S SUPPLEMENTAL CONSOLIDATED MOTION TO DISMISS; AND PLAINTIFFS’ MOTION TO CERTIFY QUESTIONS OF LAW TO STATE COURTS
F. Dennis Saylor IV, United States District Judge
This is a multi-district litigation (“MDL”) proceeding arising out of claims that the use of the drug Zofran by pregnant women caused birth defects. Plaintiffs allege, among other things, that defendant GlaxoSmithKline LLC (“GSK”) negligently *65and fraudulently promoted Zofran to treat pregnancy-related nausea and…
2Cases cited40 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Webb v. JarvisIndiana Supreme Court · 1991
- Rogan v. MeninoCourt of Appeals for the First Circuit · 1999
- PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
35 more not listed; retrieve them via the Exa API.